The objectives of the FDA'S office of generic drugs
Inngår i serie: NBER working paper series (6143)
Bok Engelsk utgitt 1997
Bok Engelsk utgitt 1997
Ledig
- Automatlager: 1 av 1 ledig
*001175446 *00520250613174206.0 *007ta *008020429s1997 xxu 000 u eng d *00900708cam a22002057c 4500 *019 $bl *035 $a(EXLNZ-47BIBSYS_NETWORK)990209763724702201 *035 $a(NO-LaBS)14504022(bibid) *035 $a(NO-TrBIB)020976372 *035 $a020976372-47bibsys_network *040 $aNO-TrBIB$bnob$ekatreg *24504$aThe objectives of the FDA'S office of generic drugs *260 $aCambridge, Mass.$bNBER$c1997 *300 $a32 s. *4901 $aNBER working paper series$v6143 *7001 $aMorton, Fiona M. Scott$_30208400 *7102 $aNational Bureau of Economic Research (Forente Stater)$_13074800 *830 0$aWorking paper series (National Bureau of Economic Research : trykt utg.)$x0898-2937$v6143$w999105437124702201$_13074900 *901 $a60 *999 $aoai:nb.bibsys.no:990209763724702202$b2021-11-14T19:54:18Z$z990209763724702202 ^